Ana Charrua Selected Research

Messenger RNA (mRNA)

10/2008

Cystitis is associated with TRPV1b-downregulation in rat dorsal root ganglia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Charrua Research Topics

Disease

9	Pain (Aches) 04/2022 - 11/2003
5	Inflammation (Inflammations) 04/2022 - 07/2004
5	Cystitis 01/2020 - 12/2004
3	Lower Urinary Tract Symptoms 04/2022 - 03/2015
3	Interstitial Cystitis (Interstitial Cystitis, Chronic) 10/2019 - 06/2015
2	Underactive Urinary Bladder 01/2022 - 09/2019
2	Visceral Pain 06/2015 - 03/2015
1	Heart Failure 05/2022
1	Overactive Urinary Bladder (Overactive Bladder) 04/2022
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2022
1	Pelvic Pain 01/2021
1	Chronic Pain 10/2019
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2019
1	Ischemia 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2018
1	Metrorrhagia (Spotting) 06/2015
1	Hypersensitivity (Allergy) 10/2012
1	Fatigue 01/2012
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2012
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2008
1	Bone Neoplasms (Bone Cancer) 12/2008
1	Abnormal Reflex (Hyperreflexia) 12/2004
1	Hemorrhagic Cystitis 12/2004
1	Hyperalgesia 12/2004
1	Body Weight (Weight, Body) 07/2004
1	Hyperinsulinism (Hyperinsulinemia) 11/2003

Drug/Important Bio-Agent (IBA)

4	LipopolysaccharidesIBA 01/2020 - 04/2007
4	TRPV Cation ChannelsIBA 07/2019 - 11/2003
3	Nerve Growth Factor (NGF)IBA 10/2019 - 10/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2008 - 07/2004
2	Pharmaceutical PreparationsIBA 05/2022 - 03/2015
2	anandamide (arachidonylethanolamide)IBA 01/2020 - 12/2004
2	Type A Botulinum Toxins (Botox)FDA Link 01/2018 - 01/2012
2	Adrenergic Agents (Adrenergic Drugs)IBA 08/2017 - 06/2015
2	resiniferatoxinIBA 12/2008 - 07/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2020
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2020
1	URB937IBA 01/2020
1	EndocannabinoidsIBA 01/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	TropomyosinIBA 10/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	Serotonin (5 Hydroxytryptamine)IBA 09/2019
1	Glucose (Dextrose)FDA LinkGeneric 07/2019
1	cyclopropapyrroloindoleIBA 01/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2017
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 06/2015
1	CatecholaminesIBA 06/2015
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 06/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2015
1	RN 1734IBA 03/2015
1	N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA 03/2015
1	Urethane (Ethyl Carbamate)IBA 01/2012
1	Messenger RNA (mRNA)IBA 10/2008
1	capsazepineIBA 12/2004
1	Acrolein (Aqualin)IBA 07/2004
1	salicylhydroxamic acid (SHAM)IBA 07/2004
1	Insulin (Novolin)FDA Link 11/2003
1	Insulin ReceptorIBA 11/2003
1	Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)IBA 11/2003

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2018
1	Radiotherapy 01/2019
1	Injections 01/2018
1	Spinal Injections 12/2008
1	Analgesia 12/2008
1	Urinary Catheters 07/2004